2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
Also known as: - Nitrosamine Impurities or nitrosamine impurities of -| Product Name | 2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one |
|---|---|
| Alternate Names | - Impurities, Impurities of - |
| CAT No. | CS-O-42672 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 164.12 g/mol |
| Mol. For. | C6H4N4O2 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one is a chemical compound that has been extensively studied due to its potential as a therapeutic agent. It is commonly used in the pharmaceutical industry for its antimicrobial and anticancer properties.
The compound's chemical structure consists of a pyridine ring attached to a triazole ring, with a nitroso group and a carbonyl group located at positions 2 and 3 respectively. This unique structure makes it a potent inhibitor of enzymes involved in DNA synthesis, leading to its potential anticancer activity. Additionally, it has been shown to have antimicrobial activity against a range of bacteria and fungi, making it useful in the treatment of infectious diseases.
The compound's usage and chemical properties have been the subject of extensive research. It is known to undergo nitrosation reactions, leading to the formation of nitric oxide, a potent signaling molecule with various physiological functions. Additionally, its ability to inhibit enzymes involved in DNA synthesis has been extensively studied, with promising results in cancer therapy.
Overall, 2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one is a versatile compound with significant potential in the pharmaceutical industry. Its unique chemical structure and potent biological activity make it a promising therapeutic agent for the treatment of a range of diseases.
![Picture of 2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one](https://clearsynth.com/structure/2-nitroso--1-2-4-triazolo-4-3-a-pyridin-3-2H--one.png)
Get an Instant Quote
Related Compounds
Triethanolamine phosphate | Dydrogesterone Impurity C | Safinamide ring closed impurity | Chlorpromazine Hydrochloride - Impurity B | PEG-8 Laurate | Aminodihexylquat Nitroso Impurity | cisplatin dihydrate impurity | Methoxy polyethylene glycol succinate N-hydroxy succinimide | ethyl 2-((3,5,6-trichloropyridin-2-yl)oxy)acetate | Butyric-3,3-d2 Acid | PZ 15227 | Diethoxyethane | Fmoc-O-tert-butyl-D-trans-4-hydroxyproline | methyl 3,4-dihydro-2H-1,4-benzothiazine-6-carboxylate | Samidorphan isoquinoline dioxolane | Polybutylene terephthalate Impurity 1 | iopamidol Impurity 4 | Sacubitril Impurity 57 | Benzene,1,2-Dichloro-3-(dibromomethyl) | Triethyl 1,3,5-benzenetricarboxylate | N-(4-(3-ethoxy-2-hydroxypropoxy)phenyl)-3-hydroxypropanamide | Dextrates monohydrate | Gamma-glutamyl-2-naphthylamide | Methyl 4-chloro-3-(chlorosulfonyl)thiophene-2-carboxylate | Resmetirom Impurity 2 | Larotrectinib Urea dimer impurity | S-(5-(dimethylamino)-2-((4-(dimethyliminio)cyclohexa-2,5-dien-1-ylidene)amino)phenyl)sulfothioate | Zanubrutinib Mesyl impurity | Fmoc-Val-Ser[Psi(Me,Me)Pro]-OH | Demethyloleuropein Aglycone | Nifuraldezone | N-(4-acetamidobenzoyl)-L-glutamic acid | Diethyl 2-(2-(4-chlorophenyl)allyl)-2-((2-oxo-1,2-dihydroquinolin-4-yl)methyl)malonate | Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside | Nandrolone furylpropionate | Tadalafil Impurity D (R,S)Isomer | ethyl 2-hydroxyethane-1-sulfonate | S-Acetyl L-Glutathione | YD-19 | Phenyl hydrazine 13C6 HCl | Adlupulone | Cadmium Hydroxide | Amurensin A | Fluconazole Impurity 27 Chloride | Black cohosh | GLP-0492-13C,d3 | trimethylsulfonium p-toluenesulfonate (TMSI) | Sofosbuvir impurity A | Salmeterol Related Compound H | Enpp1-IN-3 | Ulinastatin JP Reference standard (3700 units) | phenylpicolinate | diethyl 2-(((3-chlorophenyl)(nitroso) amino)methylene)malonate | Sugammadex sodium impurity 50 | Methyl 2',3'-dichloro-5-methyl-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate | Sacubitril Impurity 13 | Vonoprazan Impurity 15Impurity | Sacubitril Impurity 14 | Tandospirone Citrate Impurity I | Fidaxomicin Related Compound L | Tri-p-tolyl Phosphite | N-Nitroso Venetoclax intermediate( VNL6) | Nu-chek mix 17A impurity | Methyl 3-(4-methoxyphenyl)-2-methyloxirane-2-carboxylate | Methyl nonadecanoate | Ribociclib Impurity B | Lubiprostone Related Compound 7 | Cevimeline disulfide dimer | Tolvaptan Impurity 31 | ONT 993 |